Receive a board briefing pack that frames the model lag questions every non-executive director should be asking.

Board Oversight of Model Lag Starts with the Right Questions

# Is Your Reinsurance Strategy Exposed to Capital Models That Lag Portfolio Change?

Yes, if the board approves underwriting strategy, capital allocation, and risk appetite based on model output that reflects the portfolio of eighteen months ago. Every decision the board makes that depends on the model's capital requirements, pricing the cost of capital, allocating capacity across lines, setting risk tolerance, approving retrocession strategy, is systematically misinformed if the model's calibration lags the current portfolio. The board that does not ask about model lag is governing on the basis of a risk measurement that may no longer describe the risk the group is running. The exposure of the reinsurer's strategy to model lag is a governance question that every board should be asking, because the answer determines whether the board's strategic decisions are grounded in current reality or historical assumption.

## Why must the board ask about model lag now?

The pace of portfolio change in the current market has widened the potential gap between model calibration and portfolio reality. Rapid premium growth in hard-market lines, entry into new risk classes, and significant changes in retrocession structure all create divergence between the portfolio the model was calibrated to and the portfolio the group is writing. A board that approved strategy six months ago based on a model calibrated eighteen months ago is governing on information that is two years out of date relative to the current portfolio. Read [Reinsurance 2026: Ten Forces Reshaping the Industry](https://insurnest.com/blog/reinsurance-2026-ten-forces/) for the market dynamics driving portfolio change.

Regulatory expectations demand board oversight of model risk. The PRA's senior insurance managers regime and Solvency II's system of governance require directors to satisfy themselves that the information they use for governance decisions is adequate. A director who approves the ORSA without questioning whether the underlying model reflects the current portfolio may face personal regulatory exposure. The board's questions about model lag are not optional governance enhancements; they are regulatory requirements. Visit [Insurnest](https://insurnest.com) for board governance infrastructure. For the strategic framework, see [Enterprise Risk and Strategic Reinsurance](https://insurnest.com/blog/enterprise-risk-strategic-reinsurance/) and [Solvency Relief and Reinsurance Capital: Strategic Dimensions](https://insurnest.com/blog/solvency-relief-reinsurance-capital/).

## What goes wrong when the board does not ask about model lag?

When the board accepts model output without questioning its currency, each one below converts a model governance gap into strategic decisions made on stale information.

### 1. How does the board unknowingly approve strategy based on a portfolio that no longer exists?

The board approves an underwriting strategy with growth targets, capital allocations, and return expectations derived from the model's output. If the model reflects last year's portfolio, the strategy is built on a foundation that no longer describes the business. The growth target may be unachievable because the model understates the capital required. The return expectations may be unrealistic because the model understates the risk. The board approves a strategy it believes is grounded in analysis when in fact the analysis describes a portfolio the group stopped writing a year ago.

### 2. How does the board unknowingly approve a risk appetite calibrated to stale risk measurement?

The board sets risk tolerance based on the model's SCR and risk metrics. If the model understates SCR for growing lines, the board's risk appetite is effectively wider than intended because the capital buffer is thinner than the board believes. The board approves a risk position it would not approve if the model reflected the current portfolio. The governance failure is not the board's risk appetite decision itself but the information on which it was based.

### 3. How does the board unknowingly approve capital allocation that perpetuates misallocation?

The board approves the annual capital plan based on the model's allocation. If the model over-allocates to shrinking lines and under-allocates to growing lines, the board is approving a capital deployment that is suboptimal relative to current opportunities. The board believes it is governing capital allocation when it is ratifying a model-driven misallocation.

### 4. How does the board's silence on model lag weaken its standing with regulators?

When a regulator reviews board materials and finds no evidence that the board has questioned model currency, the regulator concludes that model risk governance is weak. This conclusion may lead to more intensive supervision, capital add-ons, or formal requirements to strengthen model governance. The board's credibility with its primary external stakeholder is diminished.

### 5. How does the board's failure to ask about model lag expose directors to personal liability?

Under senior insurance managers regimes, directors are personally accountable for decisions made in their areas of responsibility. A director who approves the ORSA or the risk appetite without satisfying themselves that the underlying model is appropriate may be exposed to regulatory enforcement action if that decision proves to be materially misinformed. The board's questions about model lag are a personal liability protection as well as a governance responsibility.

> **The board that does not ask about model lag does not govern model risk. Start asking.**
>
> [Talk to Our Specialists](https://insurnest.com/contact-us/)
>
> Visit [Insurnest](https://insurnest.com) to equip your board with the model lag governance framework.

## What questions should the board ask about model lag?

The board should ask five categories of questions: model currency, strategy exposure, capital allocation impact, risk appetite calibration, and governance effectiveness. Consider the Risk Committee of a Bermudian reinsurer that developed a model lag question framework after a recalibration increased SCR by 15% and forced the board to approve an unplanned capital raise. The committee realised that the model lag had been accumulating for eighteen months and that the board had approved strategy, capital allocation, and risk appetite during that period on the basis of the stale model. The committee developed a structured question set to prevent recurrence.

The question set transformed the board's model governance. Management now presents a model lag assessment quarterly alongside the SCR. The board's strategy discussions now reference both model-based and current-portfolio-adjusted metrics. The board has not been surprised by a recalibration since. That is what every board should be doing: asking the questions that prevent model lag from undermining strategic governance.

- **"Show us the comparison between the portfolio the model was calibrated to and the portfolio we are currently writing, with an estimate of the capital impact of material differences."** This is the foundational question that makes model lag visible to the board.
- **"What is the basis of the capital allocation, pricing, and return projections in the strategy we are being asked to approve? Are they model-based or current-portfolio-adjusted?"** The board should understand the information basis of every strategic decision it makes.
- **"What is the model lag indicator for our material lines, and what is the trend over the last four quarters?"** The indicator should be a standing item in the quarterly capital report, enabling the board to track lag over time.
- **"Are there any lines where the model is not calibrated, and what interim capital treatment is being applied?"** New lines without model calibration require board attention to ensure interim charges are prudent.
- **"Does our risk appetite framework include a model risk tolerance, and are we operating within it?"** If the framework does not address model risk, the board should direct management to add a model risk metric.
- **"Does our ORSA incorporate a model lag sensitivity analysis showing the impact on projected solvency if calibration differs from portfolio composition?"** The board should require this analysis and should discuss it before approving the ORSA.
- **"What is the recalibration timeline for lines where model lag is material, and is the model change process fast enough to keep pace with portfolio change?"** The board should satisfy itself that the calibration cycle is adequate for the current pace of portfolio evolution.
- **"How accurate have our pre-recalibration adjusted estimates been compared to post-recalibration actuals? What does that tell us about our estimation methodology?"** Back-testing provides the board with evidence of estimation reliability.
- **"Do our regulatory filings, investor communications, and rating agency discussions appropriately disclose model lag and its management?"** The board should ensure that external communications do not conceal material model risk.
- **"What independent assurance do we have that model lag is being identified, measured, and managed effectively?"** The board should commission periodic independent review from internal audit or external advisors.

## How can boards build model lag governance capability?

Building this capability requires defining the board's information requirements, embedding model risk in the risk appetite framework, integrating with ORSA governance, establishing independent assurance, and sustaining the questioning discipline. Each addresses one of the governance failures above.

### 1. How should the board define its model lag information requirements?

The board should specify the model lag information it requires quarterly: a model lag indicator for material lines, current-portfolio-adjusted SCR alongside model-based SCR, pricing overlays and capital reallocations applied, recalibration timeline, and expected recalibration impact. The specification should be documented in the board information policy. The [Capital Relief Estimation AI Agent](https://insurnest.com/agent-details/insurance/reinsurance/capital-relief-estimation-ai-agent-in-reinsurance-of-insurance/) and the [Multi-Treaty Exposure Tracker AI Agent](https://insurnest.com/agent-details/insurance/reinsurance/multi-treaty-exposure-tracker-ai-agent-in-reinsurance-of-insurance/) provide the data.

### 2. How should model risk be embedded in the risk appetite framework?

The board should approve a model risk tolerance specifying the acceptable divergence between model-based and current-portfolio-adjusted capital requirements. The tolerance should be reported against quarterly, with breaches triggering defined response. For governance framework, see [Credit Reinsurance Through the Cycle](https://insurnest.com/blog/credit-reinsurance-through-the-cycle/).

### 3. How should model lag oversight be integrated with ORSA governance?

The board should require that every ORSA submission includes a model lag sensitivity analysis. The board should discuss this analysis before approving the ORSA and should record its consideration in the board minutes. The [Reinsurance Risk Aggregation AI Agent](https://insurnest.com/agent-details/insurance/reinsurance/reinsurance-risk-aggregation-ai-agent-in-reinsurance-of-insurance/) supports the sensitivity analysis.

### 4. How should the board establish independent assurance on model lag?

The board should commission periodic independent review of model lag identification, measurement, and management from internal audit or external advisors. The review should validate that management's model lag picture is complete and that decision rules are applied consistently.

### 5. How should the board sustain its model lag questioning discipline?

Model lag should be a standing quarterly agenda item for the Risk Committee. The committee should use the structured question set at each meeting and report to the full board. For the governance sustainability framework, see [Enterprise Risk and Strategic Reinsurance](https://insurnest.com/blog/enterprise-risk-strategic-reinsurance/).

### 6. How should the board communicate its model lag oversight to external stakeholders?

The board should ensure that regulatory filings and rating agency communications include appropriate disclosure of the board's model risk governance. Rating agency meetings should include discussion of model lag oversight, demonstrating board-level ownership. For communication framework, see [Emerging Risks: The Reinsurance Watchlist](https://insurnest.com/blog/emerging-risks-reinsurance-watchlist/).

> **The board's questions about model lag define the quality of its model risk governance.**
>
> [Talk to Our Specialists](https://insurnest.com/contact-us/)
>
> Visit [Insurnest](https://insurnest.com) to equip your board with the model lag governance framework.

## What does board model lag governance deliver in practice?

Return to the Bermudian reinsurer's Risk Committee. Two years after implementing the question framework, the board now receives quarterly model lag assessment alongside the SCR. Model risk tolerance is embedded in the risk appetite framework. The ORSA includes model lag sensitivity analysis. The board has not experienced a recalibration surprise. The regulator has acknowledged the board's model risk governance as a strength. The board's strategic decisions are made with awareness of the information basis, both model-based and adjusted, underpinning them.

The broader reflection is that the board's primary model risk governance tool is the questions it asks. A board that asks detailed, evidence-based questions about model lag will receive the information and management attention required to address it. A board that does not will govern on the basis of a model that may no longer describe the risk the group is running. For more, see [Future Reinsurance Business Models: What Comes Next](https://insurnest.com/blog/future-reinsurance-business-models/).

> **Ask the questions. Govern the model risk. Protect the strategy.**
>
> [Talk to Our Specialists](https://insurnest.com/contact-us/)
>
> Visit [Insurnest](https://insurnest.com) to start your board's model lag governance journey.

## Conclusion

The board's questions about capital models that lag portfolio change define the quality of its model risk governance and, through that, the quality of its strategic governance. A board that asks only for the SCR number governs on the basis of a model that may be eighteen months out of date. A board that asks the ten questions described here governs with awareness of model currency, model limitations, and the adjustments being applied to compensate for model lag.

The questions are straightforward. They require no technical expertise beyond what directors already possess. What they require is the board's willingness to move beyond the model output that management presents and to probe the relationship between that output and the portfolio the group is actually running. Boards that make this transition govern strategy on a foundation of current reality rather than historical assumption.

## Frequently asked questions

### What is the most important question a board should ask about model lag?
The board should ask for a comparison between the portfolio the model was last calibrated to and the portfolio the group is currently writing, with an estimate of the capital impact of material differences.

### How does model lag affect the board's approval of the underwriting strategy?
The board approves strategy based on projected returns on allocated capital, capital consumption, and risk appetite utilisation produced by the model. If the model lags the portfolio, the board approves strategy based on metrics that may not reflect the portfolio the strategy will create.

### What model lag information should the board receive in its quarterly capital report?
A model lag status summary showing the lag indicator for material lines, current-portfolio-adjusted SCR alongside model-based SCR, pricing overlays and capital reallocations applied, recalibration timeline, and expected recalibration impact.

### How should the board's Risk Committee oversee model lag?
Model lag should be a standing quarterly agenda item, reviewing the lag assessment, capital impact estimate, management actions, and recalibration plan. The Committee should commission an annual independent review of model lag controls.

### How does model lag interact with the board's risk appetite framework?
The risk appetite framework should include a model risk tolerance limiting acceptable divergence between model-based and adjusted capital requirements. Without it, the board governs assuming the model always aligns with the portfolio.

### What should the board ask about the model recalibration timeline?
When was the last recalibration, when is the next scheduled, which lines have experienced most portfolio change, and is the current timeline adequate given the pace of change? The board should also ask whether the change process is fast enough for material changes.

### How can the board test whether model lag is being managed effectively?
The board can request historical comparison of pre-recalibration adjusted estimates against post-recalibration actuals. Consistent accuracy suggests reliable estimation; divergence suggests methodology improvement is needed.

### How should the board handle disclosure of model lag in external communications?
The board should satisfy itself that regulatory filings, investor communications, and rating agency discussions appropriately disclose model lag and its management, and that material lag is not concealed by aggregating model-based and adjusted metrics.

## About the author

**Hitul Mistry** is the Founder of Insurnest, an InsurTech company that engineers end-to-end technology exclusively for the insurance industry serving carriers, TPAs, MGAs, brokers, and reinsurers across India, the UAE, and the US. With more than a decade of insurance domain experience, he has built systems spanning underwriting automation, AI-powered underwriting intelligence, claims management, rating and quoting, broking and agency platforms, and reinsurance automation across Health/GMC, Group Life, Motor, P&C, and Reinsurance. Insurnest doesn't adapt generic software to insurance; it builds from the workflow up.

Connect with Hitul on [LinkedIn](https://www.linkedin.com/in/hitulmistry/).

Posts tagged with#strategy exposure

Is Your Reinsurance Strategy Exposed to Capital Models That Lag Portfolio Change?